Post-IPO Equity Biotechnology Companies

A health sciences company that develops innovative options for preventive and curative therapies .

Grey Matters Health company is focused on developing, in-licensing, and commercializing proprietary innovative.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Shortwave Life Sciences is a biotech company that develops psychedelics-based medicine.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Cyclezyme has created an enzymatic platform aimed at manufacturing enzymes for green biochemical processes.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Nanollose is a research and development company, specialising in the development of Plant-Free cellulose technologies.

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

PMGC is a biotechnology company that develops regenerative skin care applications.

Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.